Vanda Pharmaceuticals Netherlands B.V.
2 products tracked · names used in filings: Vanda Pharmaceuticals Netherlands B.V.
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Fri 12 Jun 2026🇪🇺 EU refusal
Iloperidone Vanda Pharmaceuticals (iloperidone): EU marketing authorisation refused
Thu 26 Feb 2026🇪🇺 CHMP negative opinion
Iloperidone Vanda Pharmaceuticals (iloperidone): CHMP negative opinion
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Iloperidone Vanda Pharmaceuticals iloperidone | Refused | |
| 🇪🇺 | Hetlioz tasimelteon | Authorised | 2015-07-03 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.